paclitaxel has been researched along with Carcinoma, Embryonal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthou, C; Bourge, JF; Denizot, Y; Fleet, C; Geromin, D; Leboulch, P; Michel, E; Pawliuk, R; Sasportes, M; Sigaux, F; Soulié, A | 1 |
| Bokemeyer, C; Hartmann, JT; Kuczyk, M; Malenke, E; Mayer, F; Mueller, S | 1 |
| Brozmanová, K; Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Risnyovzská, Z; Sálek, T; Svetlovská, D; Sycová-Milá, Z | 1 |
| Gerl, A; Wilmanns, W | 1 |
1 trial(s) available for paclitaxel and Carcinoma, Embryonal
| Article | Year |
|---|---|
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Embryonal; Choriocarcinoma; Cisplatin; Etoposide; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Teratocarcinoma; Testicular Neoplasms | 2007 |
3 other study(ies) available for paclitaxel and Carcinoma, Embryonal
| Article | Year |
|---|---|
Glycoprotein 170 induces platelet-activating factor receptor membrane expression and confers tumor cell hypersensitivity to NK-dependent cell lysis.
Topics: ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Embryonal; Cell Line, Tumor; Cell Membrane; Clone Cells; Cytotoxicity, Immunologic; Drug Resistance, Neoplasm; Genes, MDR; Glycoproteins; Humans; Hydrogen-Ion Concentration; K562 Cells; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Paclitaxel; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Retroviridae; Teratoma; Transduction, Genetic; Transfection | 2004 |
Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma, Embryonal; Cell Cycle; Cell Line, Tumor; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Female; Flavonoids; Humans; Inhibitory Concentration 50; Ovarian Neoplasms; Paclitaxel; Piperidines; Uterine Cervical Neoplasms | 2005 |
Antitumor activity of paclitaxel after failure of high-dose chemotherapy in a patient with late relapse of a non-seminomatous germ cell tumor.
Topics: Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Embryonal; Humans; Leukopenia; Male; Paclitaxel; Peripheral Nervous System Diseases; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia | 1996 |